Lunai Bioworks (LNAI) Revenue (2013 - 2026)
Lunai Bioworks (LNAI) posted quarterly Revenue of $20942.0 for Q1 2026, up 8482.79% quarter-over-quarter from $244.0 in Q2 2016.
Lunai Bioworks (LNAI) Revenue (2013 - 2026) Analysis & Trends
Lunai Bioworks' Revenue history runs 3 years deep, the most recent figure standing at $20942.0 for Q1 2026.
- In Q1 2026, Revenue changed N/A year-over-year to $20942.0; the TTM figure through Mar 2026 stood at $85227.0 (changed N/A YoY), while the FY2016 annual figure was $42769.0, changed N/A from the prior year.
- Revenue for Q1 2026 stood at $20942.0, up from $244.0 in the prior quarter.
- The five-year high for Revenue was $20942.0 in Q1 2026, with the low at $20942.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,942.00 |
| Jun 30, 2016 | 244.00 |
| Sep 30, 2013 | 32,483.00 |
| Jun 30, 2013 | 31,558.00 |
| Mar 31, 2013 | 31,558.00 |